| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8adec6c65f65acc63fceb85c3d3b0d9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e60c16475ac90871ce62cec98a712a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1908db4847e86ab260a46311a7e488e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdd586892077e44ae7409992ac0632a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ec826a9ae277030aa8a2fb770c27dbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72998dd8bd7802d43f757dd232da86a1 |
| publicationDate |
2016-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160054317-A |
| titleOfInvention |
Pharmaceutical Compositions Comprising Lobeglitazone for Oral Administration |
| abstract |
The present invention relates to a pharmaceutical composition for oral administration comprising robeglitazone. The pharmaceutical composition of the present invention includes a cellulose derivative and exhibits an action effect exhibiting an excellent dissolution rate and exhibiting a rapid pharmacological effect. |
| priorityDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |